genomics

Silent genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations

MSFHR is providing matching funds for the research of Dr. Laura Arbour under the Genome Canada/ Canadian Institutes for Health Research Large-Scale Applied Research Project (LSARP): Genomics and Precision Health. Additional support is provided by Genome BC, the BC Children's Hospital Foundation, BC Provincial Services Health Authority and the University of British Columbia (UBC).

Primary Investigator: 
Award Type: 
Year: 
2018

Locally produced brain insulin in memory and Alzheimer's disease: A multi-disciplinary approach to a key question

Dr. James Johnson is one of five BC researchers leading teams supported through the British Columbia Alzheimer’s Research Award. Established in 2013 by the Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia (Genome BC), The Pacific Alzheimer Research Foundation (PARF) and Brain Canada, the goal of the $7.5 million fund is to discover the causes of and seek innovative treatments for Alzheimer’s disease and related dementias.

Primary Investigator: 
Award Type: 
Year: 
2015

Novel retinal biomarkers for Alzheimer's disease

Dr. Faisal Beg is one of five BC researchers supported through the British Columbia Alzheimer’s Research Award. Established in 2013 by the Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia (Genome BC), The Pacific Alzheimer Research Foundation (PARF) and Brain Canada, the goal of the $7.5 million fund is to discover the causes of and seek innovative treatments for Alzheimer’s disease and related dementias.

Primary Investigator: 
Award Type: 
Year: 
2015

Integrating clinical, functional and chemical genomics to understand lung cancer biology

Lung cancer is the leading cause of cancer mortality worldwide. Contributing factors include the late stage of disease at the time of diagnosis and a scarcity of effective therapeutic strategies to treat advanced tumors. However, as our knowledge of lung cancer biology is increasing, targeted therapies have been developed to combat this devastating disease. These therapies target mutated components of key cellular pathways on which tumors have become dependent on for survival, yielding drastic initial response rates without the major side effects of traditional chemotherapies.

Primary Investigator: 
Award Type: 
Year: 
2014
Health Category: 

Understanding tumor microenvironment interactions in lymphoid cancers: Translation into improved treatment outcome prediction and development of personalized therapies

Malignant lymphomas are the fifth most frequent cancer in humans, affecting patients of all ages. Despite generally effective treatments, a significant number of patients still die from the progressive disease. Interactions of the malignant cells with cells of the tumor microenvironment are increasingly recognized to play a pivotal role in the development of many lymphoma subtypes. However, the clinical potential of an improved understanding of microenvironment-related biology remains largely untapped.

Primary Investigator: 
Award Type: 
Year: 
2012
Health Category: 

Transcriptional regulation of genes in health and disease

The human genome contains all the genes, and their regulatory instructions, required to develop the human body and determine how it deals with the outside environment. Now that the genomes of many species have been sequenced, a major focus of genomics is to identify all gene regulatory elements within DNA sequences. How these building blocks of life work together to build a complex human body – with its different organs, tissues, and cell types – is not well understood.

Primary Investigator: 
Award Type: 
Year: 
2007
Subscribe to RSS - genomics